Cite
HARVARD Citation
Li, S. et al. (2022). A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells. Journal of cellular and molecular medicine. 26 (20), pp. 5222-5234. [Online].